Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1991 Aug;11(1):43-8.
doi: 10.1007/BF00166996.

Malignant properties of P635 glioma are independent of glial fibrillary acidic protein expression

Affiliations

Malignant properties of P635 glioma are independent of glial fibrillary acidic protein expression

A F Chambers et al. J Neurooncol. 1991 Aug.

Abstract

To examine the relationship between the malignant behavior of rat glioma cells and expression of the differentiation antigen glial fibrillary acidic protein (GF), we assayed the tumorigenicity and metastatic ability of P635 and its GF+ or GF- clones. We injected P635 (GF+) and clone 45 (GF-) cells intramuscularly in nude mice. Both lines formed local tumors which metastasized to lungs with equal efficiency. We then injected these lines intravenously in nude mice. Both produced experimental metastases in lungs and other organs with equal efficiency. Finally we injected P635 and several GF+ and GF- clones into the chorioallantoic membrane veins of naturally immune-deficient chick embryos and measured cell growth in embryonic liver. We again found that all clones survived and grew equally well. P635 cells are capable of extracranial growth and metastasis, two important features of the malignant phenotype. We conclude that GF in P635 is a neutral marker with respect to tumorigenicity and metastatic ability.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Biomedicine. 1979 Dec;31(8):228-30 - PubMed
    1. J Comp Neurol. 1981 Aug 10;200(3):375-91 - PubMed
    1. Am J Pathol. 1987 May;127(2):358-72 - PubMed
    1. J Neuropathol Exp Neurol. 1986 Nov;45(6):704-20 - PubMed
    1. Anticancer Res. 1988 Sep-Oct;8(5A):861-71 - PubMed

Publication types

Substances